Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma

Oncology Reports

Volumn 25, Issue 4, 2011, Pages 989-995

  Than, Swe Swe ^a   Kataoka, Ken ^a   Sakaguchi, Masakiyo ^a   Murata, Hitoshi ^a   Abarzua, Fernando ^a   Taketa, Chika ^a   Du, Gang ^a   Yashiro, Masakazu ^b   Yanagihara, Kazuyoshi ^c   Nasu, Yasutomo ^a   Kumon, Hiromi ^a   Huh, Nam Ho ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Gene therapy; REIC Dkk 3; Scirrhous gastric carcinoma

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; PROTEIN REIC; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROGNOSIS; SCIRRHOUS GASTRIC CARCINOMA; STOMACH CARCINOMA; TUMOR VOLUME; VIRAL GENE THERAPY;

ADENOCARCINOMA, SCIRRHOUS; ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOENZYME TECHNIQUES; INJECTIONS, INTRAPERITONEAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; PERITONEAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 79952203032     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1149     Document Type: Article

References (23)

1. Global Cancer Facts and Figures 2007, American Cancer Society, Atlanta, 2007.
2. Liu Y, Yoshimura K, Yamaguchi N, Shinmura K, Yokota J and Katai H: Causation of Borrmann type 4 gastric cancer: heritable factors or environmental factors? Gastric Cancer 6: 17-23, 2003.
3. Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y and Sugimachi K: Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol 96: 574-578, 2001.
4. Ikeguchi M, Miyake T, Matsunaga T, Yamamoto M, Fukumoto Y, Yamada Y, Fukuda K, Saito H, Tatebe S and Tsujitani S: Recent results of therapy for scirrhous gastric cancer. Surg Today 39: 290-294, 2009.
5. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y and Namba M: A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268: 20-24, 2000. (Pubitemid 30116603)
6. Kurose K, Sakaguchi M, Nasu Y, Ebara S, Kaku H, Kariyama R, Arao Y, Miyazaki M, Tsushima T, Namba M, Kumon H and Huh NH: Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol 171: 1314-1318, 2004. (Pubitemid 38327602)
7. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH: Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 65: 9617-9622, 2005. (Pubitemid 41541434)
8. Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H and Date H: REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 16: 65-72, 2009.
9. Tanimoto R, Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kumon H and Huh NH: REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med 19: 363-368, 2007.
10. Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH and Kumon H: Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res 68: 8333-8341, 2008.
11. Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y, Ochiai K, Nasu Y, Kumon H and Huh NH: Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth induction of interleukin-7. J Biol Chem 284: 14236-14244, 2009.
12. Yashiro M, Chung YS, Nishimura S, Inoue T and Sowa M: Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis 14: 43-54, 1996. (Pubitemid 26008959)
13. Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F, Nishio K, Ochiya T, Ino Y and Hirohashi S: Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci 96: 323-332, 2005. (Pubitemid 41007466)
14. Bai L, Mihara K, Kondo Y, Honma M and Namba M: Immortalization of normal human fibroblasts by treatment with 4-nitroquinoline 1-oxide. Int J Cancer 53: 451-456, 1993. (Pubitemid 23047894)
15. Tanaka H, Yashiro M, Sunami T, Sakate Y, Kosaka K and Hirakawa K: ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 10: 4885-4892, 2004. (Pubitemid 38955543)
16. Carroll JL, Nielsen LL, Pruett SB and Mathis JM: The role of natural killer cells in adenovirus-mediated p53 gene therapy. Mol Cancer Ther 1: 49-60, 2001.
17. Budzynski W and Radzikowski C: Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol 16: 319-346, 1994. (Pubitemid 24285733)
18. Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and Kumon H: Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol 34: 657-663, 2009.
19. Topley N, Jörres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, Müller C, Coles GA, Davies M and Williams JD: Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 43: 226-233, 1993. (Pubitemid 23167470)
20. Lanfrancone L, Boraschi D, Ghiara P, Falini B, Grignani F, Peri G, Mantovani A and Pelicci PG: Human peritoneal mesothelial cells produce many cytokines [granulocyte colony-stimulating factor (CSF), granulocyte-monocyte- CSF, macrophage-CSF, interleukin-1 (IL-1), and IL-6] and are activated and stimulated to grow by IL-1. Blood 80: 2835-2842, 1992.
21. Topley N, Brown Z, Jörres A, Westwick J, Davies M, Coles GA and Williams JD: Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol 142: 1876-1886, 1993.
22. Sako A, Kitayama J, Yamaguchi H, Kaisaki S, Suzuki H, Fukatsu K, Fujii S and Nagawa H: Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis. J Surg Res 115: 113-120, 2003. (Pubitemid 37323956)
23. Engler H, Machemer TR, Schluep T, Wen SF, Quijano E, Wills KN, Harper AE, Maneval DC and Conroy SE: Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice. Mol Ther 7: 558-564, 2003. (Pubitemid 36553426)